Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
August 31, 2023
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
September 27, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
October 3, 2023
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
June 12, 2023
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
May 22, 2023
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
April 26, 2023
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
April 17, 2023
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
February 21, 2023
Quantum Motion Raises £42 Million Investment Round
All News
09•01•24
Portfolio News
Ultromics
Ultromics announces partnership to expedite development of Echo AI algorithm
07•11•23
Portfolio News
Ultromics
CMS publishes final Clinical APC rule for Ultromics EchoGo® Heart Failure
02•08•23
Portfolio News
Ultromics
New Technology Add-On Payment (NTAP) for Ultromics: Advancing HFpEF Diagnosis
31•07•23
Portfolio News
Ultromics
Study Confirms Ultromics’ AI Can Improve HFpEF Detection Using a Single Echocardiogram View
26•04•23
Portfolio News
Ultromics
Ultromics granted FDA Breakthrough Device Designation
06•12•22
Portfolio News
Ultromics
Ultromics receives FDA clearance for its breakthrough device EchoGo Heart Failure
28•09•22
Portfolio News
Ultromics
Ultromics joins FNIH partnership to transform heart failure detection
15•02•22
Portfolio News
Ultromics
Ultromics: Wolverhampton NHS cardiologists to use new cloud technology to interpret echocardiograms
15•12•21
Portfolio News
Ultromics
Ultromics breakthrough study shows AI is a capable of independently reading stress echocardiograms
09•11•21
Portfolio News
Ultromics
Caption Health and Ultromics partner to put heart disease detection and management tools in more hands
01•10•21
Portfolio News
Ultromics
Ultromics announces collaboration with Janssen to develop AI for patients with amyloidosis with cardiac involvement
15•08•21
Portfolio News
Ultromics
Ultromics raises $33 million in Series B funding to help transform cardiac disease treatment
17•06•21
Portfolio News
Ultromics
Ultromics: EchoGo predicts cardiac-related COVID-19 mortality revealed in WASE study
19•04•21
Portfolio News
Ultromics
Ultromics CE mark's EchoGo Core
06•01•21
Portfolio News
Ultromics
Ultromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal